Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SPL (Changzhou) is a specialized manufacturer of animal-derived active pharmaceutical ingredients (APIs), primarily focusing on heparin sodium and pancreatin. Located in Changzhou, China, the company serves as a strategic production hub for its parent organization, Scientific Protein Laboratories (SPL), which is a subsidiary of Shenzhen Hepalink Pharmaceutical Group. The facility is designed to meet international regulatory standards, including US FDA and EU GMP requirements, ensuring a reliable supply of critical biological components for the global healthcare market. SPL (Changzhou) leverages advanced extraction and purification technologies to produce high-purity ingredients used in anticoagulants and digestive health treatments. The company plays a vital role in the global supply chain by maintaining rigorous quality control and traceability for its biological products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SPL-Changzhou.